: +87% The nation's largest homebuilder profited from high demand, low unemployment, and a shortage of affordable housing.
: Outside the S&P 500, some smaller biotech firms like Madrigal Pharmaceuticals posted astronomical gains exceeding 500% . best 10 stocks to buy 2017
: +81% Like D.R. Horton, this homebuilder benefited from a strong construction cycle and record consumer confidence levels. Market Context and Trends : +87% The nation's largest homebuilder profited from
: +103% Gains were driven by breakthroughs in cystic fibrosis treatments and robust revenue growth. best 10 stocks to buy 2017
: The technology sector was the strongest performer overall, rising nearly 34% .
: Biotech and pharmaceutical companies like Vertex saw triple-digit returns due to clinical trial breakthroughs.